Quantitative procedures for evaluating added values from new markers over a conventional risk scoring system for predicting event rates at specific time points have been extensively studied. However, a single summary statistic, for example, the area under the receiver operating characteristic curve or its derivatives, may not provide a clear picture about the relationship between the conventional and the new risk scoring systems. When there are no censored event time observations in the data, two simple scatterplots with individual conventional and new scores for "cases" and "controls" provide valuable information regarding the overall and the subject-specific level incremental values from the new markers. Unfortunately, in the presence of censoring, it is not clear how to construct such plots. In this paper, we propose a nonparametric estimation procedure for the distributions of the differences between two risk scores conditional on the conventional score. The resulting quantile curves of these differences over the subject-specific conventional score provide extra information about the overall added value from the new marker.
INTRODUCTION
For a binary phenotypic outcome, numerical and graphical methods for evaluating an overall incremental value from a new set of markers over a conventional risk scoring system have been extensively studied (Bamber, 1975; Zhou et al., 2002; Pepe, 2003; Pepe et al., 2004; Greenland & O'Malley, 2005; Ware, 2006; Pencina et al., 2008) . Novel generalizations of these procedures to handle censored event time data have also been proposed (Hanley & McNeil, 1982; Harrell et al., 1996; D'Agostino et al., 1997; Pencina & D'Agostino, 2004; Heagerty and Zheng, 2005; Cook et al., 2006; Cai and Cheng, 2008; Uno et al, 2009) . Evaluating the added value from the new markers with an overall summary measure is an important first step for establishing a prediction rule. On the other hand, even when the new markers have either an impressive or no meaningful overall incremental value, the next critical step is to identify patients who would or would not need the additional markers for better prediction via their conventional risk scores. Unfortunately, relatively little effort has been made for establishing a systematic, analytic procedure for such "subgroup analysis" in the statistical or medical literature (D'Agostino, 2006) .
Recently, Tian et al. (2009) proposed a procedure for this type of subject-specific level analysis by controlling a pre-specified simultaneous inference error rate. However, their proposal does not incorporate censoring and depends heavily on the choice of the utility function, a weighted average between the false positive and negative rates.
For binary outcomes, simple scatterplots of individual conventional risk scores vs. new ones provide valuable information about an overall and also personalized-level incremental values of the new markers (Gu & Pepe, 2009 ). For example, in selecting patients with advanced or endstage primary biliary cirrhosis, PBC, for orthotopic liver transplantation, five patients' baseline covariates, namely age, albumin, bilirubin, edema and prothrombin time, were identified to be important predictors for the patient's survival based the data from a Mayo Clinic study (Dickson et al., 1989; Fleming and Harrington, 1991, pp. 160) . Suppose that we would like to know the added value from the bilirubin measure over the other four variables with respect to prediction of 5-year survival based on observations from 416 patients with complete information on those predictors. To this end, we first obtain a risk score based on these four variables without bilirubin, 0.29 ¢ (age/10) ¡ 3.49 ¢ log (albumin) 1.33 ¢ edema 3.07 ¢ log (prothrombin time), p1.1q
by fitting the data with a simple additive Cox model using partial likelihood estimation procedure (Cox, 1972) . Based on (1.1) and the standard Breslow estimator for the baseline cumulative hazard, we obtain individual patients' 5-year cumulative mortality risk, denoted by p 1i , i 1, ¤ ¤ ¤ , 416. Next, we fit the data using another additive Cox model with all five covariates including bilirubin. The resulting risk score is
p1.2q
Let p 2i denote the ith individual five-year mortality rate based on (1.2).
In the PBC dataset, there are 196 censored survival observations by Year 5 and 114 patients died during this time period. Figure 1(a) shows the scatterplot of p 1i vs. the difference pp 2i ¡p 1i q for those 114 observable "cases." The majority of those black dots in the figure are above the horizontal line, indicating that globally the bilirubin provides extra information about the 5-year mortality rate for those "cases." Moreover, for a subject with p 1 between 0.2 and 0.6, the corresponding p 2 tends to be substantially higher. Figure 1 (b) shows the scatterplot for the observable "controls," who survived and were still under follow-up by Year 5. Here, most of p 2 tend to be smaller than their p 1 , indicating that bilirubin has an overall incremental value. At the personalized level, it appears that for the survived patients whose conventional risk scores are between 0.15 and 0.35, bilirubin provides nontrivial improvement for predicting survival beyond 5 years. If there were no censored observations in the data, the scatterplots in Figure   1 , coupled with the standard lowess curves for the scatter diagram (dark curves), would provide a valuable tool for quantifying global and subject-specific level performance using Model (1.2) with bilirubin. Unfortunately, for the present example, the number of censored observations is substantial and it is not clear how to construct valid plots like Figure 1 .
In this paper, with censored survival data we propose a nonparametric procedure to consistently estimate quantiles of the distributions of the difference pp 2 ¡ p 1 q given p 1 for cases and controls. The resulting quantile curves are then presented using a similar configuration to Figure   1 . The new method is derived under a more general setting. Here, a case is defined as the survival time being in a time interval I 1 , while a control is defined as the survival time in an interval I 0 , where I 1 is entirely on the left hand side of I 0 . By repeating the analysis with various pairs of I 0 and I 1 , one may find, for example, that the new predictors are not useful when these two intervals are widely separated (for instance, short-vs. long-term survival), but may have substantial incremental values when these two intervals are relatively close. This type of finding can be quite informative for cost-benefit decision making. The new procedure is illustrated with the above Mayo Clinic data and also with the data set from a breast cancer study to evaluate the additional prediction ability based on a new gene risk score on top of conventional clinical markers. The second example is particularly interesting due to the fact that it is relatively expensive to measure the gene score compared with clinical markers, which are routinely obtained after patients' surgery for breast cancer.
ESTIMATING THE DISTRIBUTION OF THE NEW RISK SCORE CONDITIONAL ON THE OLD RISK SCORE
Let T be the time to an event of interest and Z be its corresponding vector of baseline covariates. For the two specific time intervals I 1 rt 1 , t 2 q and I 0 rt 3 , t 4 q discussed in Section 1, suppose that for a given Z we are interested in estimating the risk of a case:
Let U and V be two vectors, which are functions of Z. Here, U is a function of conventional markers only, but V is a function of both conventional and new predictors. One of the questions is how to identify patients with U, who may need V for better prediction of (2.1). This is a particularly important question when it is costly or invasive to measure the new markers. Often, the event time T may be censored by a censoring variable C. Assume that C is independent of T and Z. Let Gp¤q be the survival function of C. Moreover, let the binary variable E 0, if T I 0 ; 1, if T I 1 . Note that one can assign an arbitrary value (other than 0 or 1) for E when T is outside of these two time intervals. Now,
. . , nu be n independent copies of pT, C, E, Z, U, V q . For T i , we observe tX i , ∆ i u, where X i min pT i , C i q, and ∆ i 1, if X i T i , and 0, otherwise, i 1, ¤ ¤ ¤ , n. Due to potential censoring, the binary variable E may not be observable.
To construct a risk score system with U, let us consider the standard Cox proportional hazards model with the risk score β I U, where β is an unknown vector of regression parameters. With the above observed data, letβ be the maximum partial likelihood estimator for β. In practice, this semi-parametric model is simply an approximation of the "true" model. Under a mild condition, β converges to a constant, as n Ñ V (Hjort,1992) , regardless of the adequacy of the Cox model.
This property is critical for developing our new procedure. Similarly, for V, we fit the data with another additive Cox's model with the risk score γ I V. Letγ be the corresponding estimator for γ.
Now, consider an independent future subject from the same study population whose
pT, E, Z, U, V q pT 
Similarly, letp 2 pV (2009) and Uno et al. (2009) to summarize the overall incremental value of the new markers.
In this paper, we are also interested in the subject-specific level evaluation for the incremental values, that is, estimating the distribution ofDpZ
where e is either 0 or 1, and p belongs to J r l ,  r s is a strictly inner subset of the support of p 1 pU 0 q. Let q τ e ppq be the τ th conditional quantile of the above distribution, for 0 τ 1. To estimate q τ e ppq, we utilize a nonparametric quantile regression estimation technique by letting the quantile ofp 2 pV 0 q be locally linear inp 1 pU 0 q (Yu & Jones, 1998) . Specifically, without censored observations, for any given p, we minimize the following objective function with respect to a and b,
where K h pxq Kpx{hq{h, Kp¤q is a symmetric probability density function, h is a bandwidth such that h Opn ¡ν q with ν p1{2, 1{5s and ρ τ pxq is the check function, which is τ x if x ¥ 0, and is pτ ¡ 1qx if x 0. Here, we choose a proper transformation ψtp 1 pUqu ofp 1 pUq to improve smoothing, where ψp¤q : p0, 1q Ñ p¡V, Vq is a known, non-decreasing function (Wand et al., 1991; Park et al., 1997) . For example, one may let ψppq log t¡ log p1 ¡ pqu . Let the minimizer of (2.2) beâ andb. Then letq τ e ppq ψ ¡1 pâq ¡ p p2.3q
be an estimator for q τ e ppq.
Since E may not be observable in (2.2), we replace IpE eq by IpE X eq, with an inverse probability weighting technique, where E X is 1 if X I 1 ; 0 if X I 0 . Specifically, letĜp¤q denote the Kaplan Meier estimator of Gp¤q and let η be a pre-specified time point such that Gpηq ¡ 0. 
This inverse probability weighting adjustment, coupled with (2.2), results in the following minimand:
Then, the corresponding estimatorq τ e ppq for q τ e ppq is given by (2.3), but withâ being a minimizer of (2.4) with respect to a and b. In the Appendix, we show that for each fixed τ, sup pJ |q τ e ppq ¡ q τ e ppq| Ñ 0, in probability as n Ñ V.
In practice, it is important to know how to choose the smooth parameter h in the above nonparametric estimation. To this end, we consider a commonly used K-fold cross-validation procedure. Specifically, we randomly partition the data into K disjoint parts, I 1 , ¤ ¤ ¤ , I K . For each k, we use the data not in I k to obtain the regression parameter estimators in the above two
Cox's models, denoted byβ p¡kq andγ p¡kq . Moreover, let tp 1p¡kq p¤q,p 2p¡kq p¤q,q τ ep¡kq p¤qu denote the respective estimators corresponding to tp 1 p¤q,p 2 p¤q,q τ e p¤qu based on data not in I k . We propose to choose h by minimizing
p2.5q
In practice, the lower and upper bounds of J may be chosen as, for example, the 3rd and 97th
percentiles of the empirical distribution ofp 1 pU 0 q.
EXAMPLES
First, let us revisit the PBC example discussed in the Introduction Section. Figure 2 gives the Kaplan-Meier estimate with the survival times from 416 patients. Assume that we are interested in two time intervals, I 0 p5, Vq(years) and I 1 r0, 5s (years). On average the 5-year cumulative mortality rate is about 0.3. Here,p 1 pU i q is obtained without using bilirubin and p 2 pV i q is with bilirubin, i 1, ¤ ¤ ¤ , n, via the risk scores (1.1) and (1.2) and two working Cox's models. To estimate q τ e p¤q, we let ψ in (2.4) be the logp¡ logq function and the kernel function be the standard normal density function. To choose the smooth parameter h, we used 10-fold cross validation scheme with (2.5). For instance, to estimate the median q 0.5e p¤q for patients who would die by Year 5, the resulting "optimal" h with respect to ψ-scale is 1.6. The interval J over which we construct the median curves is p0.10, 0.995q. we provide the density function estimate ofp 1 score. The majority of patients whose risk scores without using bilirubin are between 0.1 and 0.6. Based on Figure 3 , the distributions ofD for "cases" over the interval p0.1, 0.995q have more positive mass, especially forp 1 between 0.2 and 0.6. The bilirubin helps greatly for the "controls" whenp 1 is between 0.2 and 0.6, that is, the false positive rate can be drastically reduced with bilirubin. We have also examined extensively the added values of bilirubin for various sets of time intervals I 0 and I 1 . In Figure 4 , we present the plots of estimated median curves for cases and controls with respect to four different sets of time intervals I 0 and I 1 . If bilirubin were not routinely measured for evaluating liver function clinically, one would recommend its usage for future subjects whose "conventional" scores were between 0.2 and 0.6. Note that we cannot estimate the medians well for controls beyond 0.6 with this set of data.
Next, we use a more interesting example to illustrate a scenario in which a non-trivial cost is associated with measuring a new marker. The data set used for our illustration is from a breast cancer study to evaluate a new genetic marker, "wound-response gene expression signature," for predicting patients' survival (Chang et al., 2005 Figure 5 . First, assume that we are interested in I 0 p10, Vq (years) and I 1 p0, 10s (years). For our analysis, we used the standard normal kernel and the logp¡ logq as the ψ function in the nonparametric estimation of the quantiles. Moreover, we used 10-fold cross validation procedure to choose h. For example, for estimating the medians, the optimal h for "cases" is 3.25 with respect to the ψ-scale and J is p0.15, 0.85q. Figure 6 (a) gives the median curve (solid curve) and the bands whose boundaries are the 0.25 and 0.75 quantile curves for "cases."
The x-axis is the score without using gene expression data. Figure 6 (b) gives the counterparts for "controls," those subjects who would survive beyond 10 years. The density function estimate of p 1 is given in Figure 6 (c). The "conventional scores" of the majority of patients in this population are between 0.2 and 0.75. Note that the median curve is in the positive (negative) side for cases (controls). The improvement from the gene score, however, is quite modest uniformly over the conventional score. Since it is relatively expensive to measure the gene score compared with the routinely obtained clinical marker values, it is not clear from cost-benefit view if we should measure the gene score for any future patient. In Figure 7 , we present plots of estimated median curves for cases and controls with respect to various sets of time intervals I 0 and I 1 . Again, there seems no obvious gain from measuring gene score for predicting survival.
REMARKS
If a study is designed for evaluating the incremental value from new predictors with respect to a specific set of time intervals I 0 and I 1 , a global Cox model may not be appropriate for establishing the risk scores due to the fact that the resulting regression coefficient estimates reflect an average covariate effect over the entire study time. For this case, we may use, for example, the logistic regression for modeling the probability of a binary variable with two events tT I 1 u and tT I 0 u with predictors and use the technique developed by Uno et al. (2007) to obtain the risk scores. Then with the same argument in the present paper, nonparametric function estimates for conditional quantiles can be obtained accordingly. When there is no prespecified set of time intervals of interest, one may use the Cox models to obtain unified scoreŝ β I U andγ I V first. However, it is important to note that these two scoring systems may not be comparable since we fit the data with two different models. Therefore, in this paper we convert the Cox scores to their risk counterparts with respect to a given paired I 0 and I 1 to evaluate the incremental values. By considering various sets of I 0 and I 1 in our analysis, one may identify when the new markers have practically meaningful added values for prediction. On the other hand, it is not clear how to utilize the Cox scores directly to perform such subject-level analysis without discretizing the continuous study follow-up time.
If the conventional scoring system is well-established, one may not need to fit the current data with the conventional markers. However, for this situation we recommend examining closely whether the present study population is similar to that from which the conventional score was constructed.
The graphical method presented here can also be utilized as a quantitative way to assess relative merits of two proposed models for fitting survival data. Unlike the lack of fit tests for model checking or a single summary statistic such as the likelihood ratio, the plots in Figures   4 and 7 with different sets of I 0 and I 1 provide much more information to help us to choose an appropriate model with respect to cost-benefit decision making.
It is important to note that the parametric or semi-parametric models used for constructing the risk scores are simply approximations for the true models. If the "old" model does not fit the data well, it is difficult if not impossible to determine whether the improvement from the "new" model is the incremental value from the new predictors or a better model fitting.
Appendix
Throughout, unless noted otherwise, we use the notation to denote equivalence up to o p p1q uniformly in p, À to denote being bounded above up to a universal constant, and 9
Fpxq to denote dFpxq{dx for any function F.
We use P n and P to denote expectation with respect to the empirical probability measure of tpX i , δ i , Z i q, i 1, ¤ ¤ ¤ , nu and the probability measure of pX, δ, Zq respectively. Similarly
2 q I , p θ 1 plogΛ 1 pt 1 q, logΛ 1 pt 2 q, logΛ 1 pt 3 q, logΛ 1 pt 4 q, p β I q I , p θ 2 plogΛ 2 pt 1 q, logΛ 2 pt 2 q, logΛ 2 pt 3 q, logΛ 2 pt 4 q, p γ I q I , whereΛ 1 p¤q andΛ 2 p¤q are the estimated cumulative hazard functions based on the models with U and with V respectively. Note that p
qu and for any vector x, x 1 p1, 0, 0, 0, x I q I , x 2 p0, 1, 0, 0, x I q I , x 3 p0, 0, 1, 0, x I q I , and x 4 p0, 0, 0, 1, x I q I .
To establish the consistency of the proposed estimator, we assume that h Opn ¡ν q with 1{2 ¡ ν ¡ 1{5 and p θ converges in probability to a deterministic vector θ 0 pθ I q,p oi p 1 pU i q, p ni p 2 pV i q, P 0 ppq P pE i 0 |p oi pq, P 1 ppq P pE i 1 |p oi pq and ζ ep pxq denote the conditional density of ψpp ni q givenp oi p and E i e which is assumed to be continuously differentiable. We assume that ξpxq, the density function of ψpp oi q, is continuously differentiable with bounded derivatives and bounded away from zero for x J . We also assume that U and V are bounded, θ 0 is an interior point of a compact set Ω. Furthermore, p θ is a regular estimator of θ 0 with
where (Kalbfleish and Prentice, 2002) . It follows that
It follows that sup d,pr l ,rs |PtDpZ to show thatq τ e ppq is uniformly consistent forq τ e ppq.
For the ease of notation, we next establish the consistency of the conditional medianq 0.5e ppq for the case with e 1 and note that similar arguments can be used for other quantiles. For any given p, let appτ e ppq p and bppq 9 appq for τ 0.5 and e 1, p E i ppq ψpp p oi q ¡ ψppq, tp appq, p bppqu be the minimizer of
Our objective is to show that sup p |p εppq| Ñ 0 in probability as n Ñ V. To this end, we note that for any given p, p εppq is the minimizer of the objective function p Lpε; pq 0, where ε pε a , ε b q I ,
and Gpε, p; yq appq bppqty ¡ ψppqu ε a ε b h ¡1 ty ¡ ψppqu. 
and w i ∆ i {GpX i q, First, following directly from (5¤2), sup ε;p E 1 pε; pq o p p1q. Secondly, with the standard arguments used in Bickel & Rosenblatt (1973) , sup ε;p |E 2 pε; pq| O p tpnhq ¡ 1 2 logpnqu o p p1q. Lastly, for E 3 pε; pq, we note that from the inequality that
where H n pu 1 , u 2 , u 3 , u 4 q P n wE X |ψpp n q ¡ Gpε, p; ψpp o qq| tIp p
Furthermore, it follows from integration by parts,
}θ 1 ¡θ 10 } ¤ δ, u 1 , u 2 , u 3 , u 4 , ε, pu, indexed by pθ 1 , u 1 , u 2 , u 3 , u 4 , ε, pq, is Donsker, the stochastic pro-
is stochastically continuous in θ 1 . This, coupled with the fact thatθ 1 ¡ θ 10 o p p1q, implies that 
